Last Updated: 01/07/2023
MediFind is the industry authority on identifying the leading medical experts and latest research in order to help patients facing complex health challenges, including Hereditary Retinoblastoma, make better health decisions. Leveraging our expertise in natural language processing and machine learning across thousands of diseases, we uncover physicians who are leading authorities on Hereditary Retinoblastoma. MediFind identifies these experts using proprietary world-class models that assess over 2.5 million global doctors based on a range of variables, including research leadership, patient volume, peer standing, and connectedness to other experts. Learn more about our methodology by exploring how MediFind works.